Francesco Gatto was interviewed by Labiotech.eu on the transition from academia to start-up, the science behind Elypta and the unmet need in cancer we aim to address.
We welcome partnerships with academia to explore clinical applications as well as industry for the development of companion diagnostics.
We welcome interest from investors and are happy to provide more information on our plans on request.
We are always looking to interact with top talents interested in joining our development team.
Elypta AB, Nanna Svartz väg 4, 171 65 Solna, Sweden